Effect of Kinesiotaping on Muscle Activity

The Effect of Kinesiotaping on Bioelectrical Muscle Activity

The aim of the investigator's study is to analyze the effect of kinesiotaping (KT) on the electrical activity of the muscle by using time and frequency domain analysis of the electromyography (EMG) signals.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Other: Kinesiotaping

Detailed Description

The kinesiotaping (KT) is a taping technique that is commonly used to improve muscle performance and facilitate or inhibit muscle activity in rehabilitation. A study reported that KT application did not change electrical activity in the early period (immediately after KT, 5th and 10 minutes after KT). However, another study showed that EMG activity increased 24 hours after KT application. A study revealed that the KT produced more EMG activity compare to placebo taping. In conclusion, the effect of KT on electrical muscular activity was arguable in the literature.

• Study Type: Interventional
• Enrollment (Actual): 38
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Istanbul, Turkey
    • Bezmialem Vakıf University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• To be right-handed-dominant
• To have normal or corrected vision
• To have no formal history of any resistance training.

Exclusion Criteria:

• To have history of neurological or recent musculoskeletal injury

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Kinesiotaping Group; The group in which kinesiotaping is going to be applied to biceps brachii muscle of participants and will assess EMG activities before KT, immediately after KT, after 30 minutes and 24 hours of KT. The EMG analysis will be performed during maximum isometric voluntary contraction of biceps brachii muscle.	Other: Kinesiotaping; For kinesiotaping, the elbow positioned in 30°-45° flexion and kinesiotaping facilitation technique is applied origin to insertion of biceps brachii muscle.
No Intervention: Control Group; The group in which kinesiotaping is not going to be applied. EMG activities will be assessed first assessment and after 10th minutes, 30th minutes and 24th hours of the first assessment. The EMG analysis will be performed during maximum isometric voluntary contraction of biceps brachii muscle.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The first assessment of electromyographic activity	The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device before KT for KT group or as a first assessment of the control group. The test will be repeated three times.	at inclusion
The second assessment of electromyographic activity	The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device immediately after KT application for KT group or at 10th minutes after the first assessment as a second assessment of the control group. The test will be repeated three times.	after KT application for KT group or at 10th minutes after the first assessment
The third assessment of electromyographic activity	The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 30 minutes after the second assessment. The test will be repeated three times.	30 minutes after the second assessment
The last assessment of electromyographic activity	The electromyographic activity of biceps brachii muscle will be measured during elbow maximum isometric flexion by using electromyography device at 24 hours after KT application or the second assessment. The test will be repeated three times.	at 24 hours after KT application or the second assessment

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The first assessment of maximum isometric voluntary contraction torque	The produced elbow flexion torque during first EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.	at inclusion
The second assessment of maximum isometric voluntary contraction torque	The produced elbow flexion torque during second EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.	after KT application for KT group or at 10th minutes after the first assessment
The third assessment of maximum isometric voluntary contraction torque	The produced elbow flexion torque during third EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.	30 minutes after the second assessment
The last assessment of maximum isometric voluntary contraction torque	The produced elbow flexion torque during the last EMG assessment will be recorded at 90° elbow flexion using isokinetic dynamometer.	at 24 hours after KT application or the second assessment

Collaborators and Investigators

• Sponsor: Bezmialem Vakif University
• Collaborators: Istanbul University - Cerrahpasa (IUC)

Study record dates

Study Major Dates

• Study Start (Actual): August 12, 2020
• Primary Completion (Actual): August 12, 2020
• Study Completion (Actual): August 13, 2021

Study Registration Dates

• First Submitted: April 8, 2020
• First Submitted That Met QC Criteria: April 15, 2020
• First Posted (Actual): April 20, 2020

Study Record Updates

• Last Update Posted (Actual): September 5, 2021
• Last Update Submitted That Met QC Criteria: September 3, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Keywords: EMG; kinesiotaping
• Other Study ID Numbers: hdenizkulli4

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No